Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2016-04-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
独立董事关于公司董事会聘任高级管理人员的独立意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors regarding the appointment of senior management personnel, referencing compliance with regulatory guidelines and company bylaws. It does not contain financial data or detailed management reports but is an announcement related to board/management changes. The document length is short and focused on management appointments, fitting the category of Board/Management Information (MANG).
2016-04-27 Chinese
第六届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the election of the Supervisory Board Chairman and approval of the company's 2016 first quarter report. It includes a statement that the Supervisory Board has reviewed and approved the quarterly report, confirming its compliance and accuracy. The document is short (594 characters) and primarily announces the approval of the quarterly report rather than containing the full report itself. Therefore, it is not the Interim/Quarterly Report (IR) itself but an announcement related to it. However, since it is a formal resolution and approval notice from the Supervisory Board, it fits best under Board/Management Information (MANG), which covers announcements of changes in company management and board decisions. The document does not fit other categories such as Regulatory Filings or Report Publication Announcement because it contains substantive content about board decisions and report approval, not just a notice or certification.
2016-04-27 Chinese
2016年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2016年第一季度报告" which translates to "2016 First Quarter Report." It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the quarter. It also includes sections on shareholder changes, important matters, commitments, and forecasts for the next half year. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-27 Chinese
2016年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2016年第一季度报告正文" which translates to "2016 First Quarter Report". It contains detailed financial data such as revenue, net profit, earnings per share, asset and equity figures, and explanations of changes in financial statement items. It also includes shareholder information and management commitments. The presence of comprehensive financial data and analysis for a quarter indicates this is a quarterly financial report. The document length is over 14,000 characters, so it is not a mere announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-27 Chinese
职工代表大会决议公告
Board/Management Information Classification · 95% confidence The document is a short announcement regarding the election of a staff representative supervisor at a company's employee representative meeting. It includes details about the individual elected and confirms no conflicts of interest or regulatory penalties. The document length is only 443 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no mention of annual or interim reports, no voting results from a general meeting, and no regulatory certifications. The content fits best with Board/Management Information (MANG) as it relates to a change or appointment in company governance structure, specifically the supervisory board representative. Therefore, the classification is MANG with high confidence.
2016-04-27 Chinese
安徽承义律师事务所关于公司召开2015年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening and proceedings of the 2015 Annual General Meeting (AGM) of 华兰生物工程股份有限公司. It details the legality of the meeting's convening, attendance, proposals, voting procedures, and results. The document does not contain the actual annual report or financial statements but rather confirms the validity and compliance of the AGM process and resolutions. The document length is 4021 characters, which is relatively short and focused on the AGM event and voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of the AGM proposals and elections. It is not an Annual Report (10-K) or a Proxy Solicitation (PSI), nor is it a simple announcement of a report publication (RPA). Therefore, the correct classification is DVA with high confidence.
2016-04-27 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.